Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

SHR Neuro Krebs Kardio Lipid Stoffw Microb

European Society of Hypertension.
The corona-virus disease 2019 pandemic compromised routine care for hypertension: a survey conducted among excellence centers of the European Society of Hypertension.
J HYPERTENS. 2021; 39(1): 190-195. Doi: 10.1097/HJH.0000000000002703
Web of Science PubMed FullText FullText_MUG


Co-Autor*innen der Med Uni Graz
Zweiker Robert

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

The Covid-19 pandemic caused a shutdown of healthcare systems in many countries. We explored the impact on hypertension care in the Excellence Center (EC) network of the European Society of Hypertension. We conducted a 17-question electronic survey among ECs. Overall, 52 ECs from 20 European and three non-European countries participated, providing hypertension service for a median of 1500 hypertensive patients per center per year. Eighty-five percent of the ECs reported a shutdown lasting for 9 weeks (range 0-16). The number of patients treated per week decreased by 90%: from a median of 50 (range 10-400) before the pandemic to a median of 5.0 (range 0-150) during the pandemic (P < 0.0001). 60% of patients (range 0-100%) declared limited access to medical consultations. The majority of ECs (57%) could not provide 24-h ambulatory BP monitoring, whereas a median of 63% (range 0-100%) of the patients were regularly performing home BP monitoring. In the majority (75%) of the ECs, hypertension service returned to normal after the first wave of the pandemic. In 66% of the ECs, the physicians received many questions regarding the use of renin-angiotensin system (RAS) blockers. Stopping RAS-blocker therapy (in a few patients) either by patients or physicians was reported in 27 and 36.5% of the ECs. Patient care in hypertension ECs was compromised during the Covid-19-related shutdown. These data highlight the necessity to develop new strategies for hypertension care including virtual clinics to maintain services during challenging times.
Find related publications in this database (using NLM MeSH Indexing)
Angiotensin Receptor Antagonists - therapeutic use
Angiotensin-Converting Enzyme Inhibitors - therapeutic use
Antihypertensive Agents - therapeutic use
Blood Pressure Monitoring, Ambulatory -
COVID-19 - epidemiology
Delivery of Health Care -
Delivery of Health Care - epidemiology
Health Facilities -
Health Services Accessibility -
Humans -
Hypertension - drug therapy
Pandemics -
Renin-Angiotensin System -
SARS-CoV-2 -
Surveys and Questionnaires -

Find related publications in this database (Keywords)
blood pressure
hypertension routine care
renin-angiotensin system inhibitors
© Med Uni Graz Impressum